Neurogene Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Neurogene Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Neurogene Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $3.19M, a 63.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.19M -$5.49M -63.2% Sep 30, 2024 10-Q 2024-11-18
Q2 2024 $3.38M -$5.75M -63% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $3.57M -$5.87M -62.2% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $3.68M -$663K -15.3% Dec 31, 2023 10-Q 2024-11-18
Q3 2023 $8.69M -$1.31M -13.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $9.14M -$1.12M -10.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $9.43M -$1.09M -10.3% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $4.34M -$6.42M -59.7% Dec 31, 2022 10-K 2024-03-18
Q3 2022 $9.99M -$1.02M -9.25% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $10.3M -$987K -8.78% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $10.5M -$957K -8.34% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $10.8M +$612K +6.03% Dec 31, 2021 10-K 2023-03-20
Q3 2021 $11M +$610K +5.87% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $11.2M +$1.6M +16.6% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $11.5M +$1.17M +11.4% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $10.2M +$9.38M +1219% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $10.4M +$10.2M +6016% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $9.65M +$9.46M +5086% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $10.3M +$10.1M +4782% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $770K Dec 31, 2019 10-K 2021-03-25
Q3 2019 $170K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $186K Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $211K Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.